newsfilter
← Latest News
GlobeNewswire·

Kronos Bio Announces Participation in Medical and Investor Conferences in September

SAN MATEO, Calif., and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (NASDAQ:KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven